A unique US-Colombian partnership is bringing one of the most advanced cancer centers to Colombia this week.
Operated by Fundacion Cardiovascular de Colombia and managed in partnership with University of Pittsburgh Medical Center (UPMC), the opening July 28 will provide state-of-the-art medical and radiation treatments to patients who previously had to travel hundreds of miles to receive such care.
Colombia will face nearly 80,000 new cases of cancer this year, a number expected to grow to 113,000 cases annually over the next 10 years.
Dr. Ricardo Munoz, chief of the Cardiac Intensive Care Division of Children’s Hospital of Pittsburgh of UPMC, is available for Spanish- or English-language interviews.
Dr. Munoz can address questions such as:
• How will the new institute improve cancer care in Colombia?
• What types of cancer will it treat?
• What services will the center provide?
• What is UPMC’s role in the new cancer institute?
• How will the Oncology Institute and the new hospital create jobs and economic development in the region?
UPMC’s news release is below.
For interviews with Dr. Munoz, contact Brian Ruberry, 301-948-1709, email@example.com.
FCV, in Partnership with UPMC, Opens Advanced Cancer Center in Colombia
PITTSBURGH, July 27, 2016 – One of the most advanced cancer centers in Colombia, developed and managed in partnership with UPMC, is preparing to open near Bucaramanga to provide care close to home for both children and adults. The new Oncology Institute is part of a recently opened 870-bed hospital owned by UPMC’s long-time partner Fundacion Cardiovascular de Colombia (FCV), acclaimed for its high-quality cardiac care.
The 200-bed Oncology Institute at the new Hospital International de Colombia(HIC), located in the town of Piedecuesta, will provide state-of-the-art medical and radiation oncology treatments to patients who previously traveled hundreds of miles to receive such care in other regions. Colombia alone will see nearly 80,000 new cases of cancer this year, a number expected to grow to 113,000 cases annually over the next 10 years.
“UPMC is assisting us with everything from developing cancer care protocols to physician training to preparing for Joint Commission International accreditation. This collaboration will ensure that the Oncology Institute becomes the leading provider of cancer services for this region,” said Victor Castillo, M.D., chairman of FCV. This partnership, he noted, builds on FCV’s successful seven-year relationship in cardiology with Children’s Hospital of Pittsburgh of UPMC, which includes remote monitoring of pediatric intensive care unit patients by Children’s physicians.
“The opening of the Oncology Institute brings UPMC’s globally renowned cancer expertise to South America for the first time,” said Charles Bogosta, president of UPMC International and UPMC CancerCenter. “Most importantly, this is a milestone for the people of this region, who will have access close to home to high-quality, leading-edge cancer care—access that will save lives.”
Financed and operated by FCV, the Oncology Institute includes chemotherapy and highly specialized radiotherapy services, with future plans for a bone marrow transplant unit. Additionally, the institute offers a palliative care program, counseling and nutrition services, and a pain management program.
The center houses one of South America’s first Varian TrueBeam STx linear accelerators, which delivers high-dose radiation to treat the most challenging tumors, including breast, lung, prostate and head and neck cancers. The goal is to minimize disabling side effects for patients while maximizing survival.
FCV and UPMC physicians and staff will be joined for a grand opening event at the hospital on July 28, including the president of Colombia, the minister of health and other dignitaries. With the support of the Colombian government, the new hospital and cancer center are expected to create 6,000 jobs and spark economic development in the free trade zone where the facility is located.
UPMC, which operates more than 40 cancer treatment centers around the world, is acting as co-manager of the Oncology Institute and will continue to provide on-the-ground support to FCV through dedicated staff members inColombia, supplemented by visiting staff from Pittsburgh.
Through UPMC International, UPMC shares its clinical, technological and managerial knowledge and expertise with partners around the world, customizing solutions to benefit patients and regions. The goal is to transform the delivery of health care while supporting UPMC’s patient care and research mission.
# # #